Antibiotic restriction does not alter endemic colonization with resistant Gram-negative rods in a pediatric intensive care unit

被引:48
作者
Toltzis, P
Yamashita, T
Vilt, L
Green, M
Morrissey, A
Spinner-Block, S
Blumer, J
机构
[1] Case Western Reserve Univ, Sch Med, Dept Pediat, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA
[4] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA
关键词
antibiotic resistance; ceftazidime; Gram-negative aerobic bacteria; disease transmission; nosocomial infections; aminoglycoside; pediatric intensive care unit; field inversion electrophoresis; drug monitoring; drug effects;
D O I
10.1097/00003246-199811000-00035
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To test whether a ceftazidime restriction policy in a pediatric intensive care unit (ICU) could decrease the endemic rate of colonization with ceftazidime-resistant Gram-negative bacilli. Design: Prospective, pre- vs, postintervention study. Setting: University hospital pediatric ICU. Patients: Consecutive children admitted to the pediatric ICU over a 19-mo period. Interventions: After an observation period in which antibiotic use was not controlled, ceftazidime was prohibited unless the patient's microbiological results indicated that the drug was necessary for cure. Aminoglycoside use was not regulated. The size of the endemic reservoir of ceftazidime- and tobramycin-resistant organisms was determined by daily nasopharyngeal and rectal swab specimens obtained on all admissions to the ICU. Measurements and Main Results: Despite a 96% reduction in ceftazidime use, the incidence density (number of isolates/100 patient-days) of ceftazidime-resistant organisms increased through the course of the study, from 1,57 to 2.16, The incidence density of tobramycin-resistant organisms was unchanged. Ceftazidime restriction resulted in a small but nonsignificant decrease in the proportion of ceftazidime-resistant organisms acquired late (beyond 72 hrs) in the patients' ICU course (56.5% vs. 45.9%), However, there was a more substantial decrease in the proportion of ceftazidime-resistant organisms derived from species known to harbor derepressible amp C beta-lactamases (68.2% vs. 45.9%, p < .05). Conclusions: These data indicate that antibiotic restriction policies in an ICU fail to diminish the size of the endemic reservoir of antibiotic-resistant Gram-negative rods, and suggest that such policies in the absence of broader efforts to limit antibiotic use will have little impact.
引用
收藏
页码:1893 / 1899
页数:7
相关论文
共 42 条
[1]   ENTEROBACTER-CLOACAE IN A NEONATAL INTENSIVE-CARE UNIT - ACCOUNT OF AN OUTBREAK AND ITS RELATIONSHIP TO USE OF 3RD-GENERATION CEPHALOSPORINS [J].
ACOLET, D ;
AHMET, Z ;
HOUANG, E ;
HURLEY, R ;
KAUFMANN, ME .
JOURNAL OF HOSPITAL INFECTION, 1994, 28 (04) :273-286
[2]   Antimicrobial resistance in isolates from inpatients and outpatients in the united states: Increasing importance of the intensive care unit [J].
Archibald, L ;
Phillips, L ;
Monnet, D ;
McGowan, JE ;
Tenover, F ;
Gaynes, R .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (02) :211-215
[3]   RAPID GENOTYPING SHOWS THE ABSENCE OF CROSS-CONTAMINATION IN ENTEROBACTER-CLOACAE NOSOCOMIAL INFECTIONS [J].
BINGEN, E ;
DENAMUR, E ;
LAMBERTZECHOVSKY, N ;
BRAHIMI, N ;
ELLAKANY, M ;
ELION, J .
JOURNAL OF HOSPITAL INFECTION, 1992, 21 (02) :95-101
[4]   CEFTAZIDIME RESISTANCE AMONG SELECTED NOSOCOMIAL GRAM-NEGATIVE BACILLI IN THE UNITED-STATES [J].
BURWEN, DR ;
BANERJEE, SN ;
GAYNES, RP .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (06) :1622-1625
[5]   Antimicrobial resistance in fecal flora: Longitudinal community-based surveillance of children from urban Mexico [J].
Calva, JJ ;
SifuentesOsornio, J ;
Ceron, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (07) :1699-1702
[6]   ASSESSMENT OF BACTERIAL CROSS-TRANSMISSION AS A CAUSE OF INFECTIONS IN PATIENTS IN INTENSIVE-CARE UNITS [J].
CHETCHOTISAKD, P ;
PHELPS, CL ;
HARTSTEIN, AI .
CLINICAL INFECTIOUS DISEASES, 1994, 18 (06) :929-937
[7]   ENTEROBACTER BACTEREMIA - CLINICAL-FEATURES AND EMERGENCE OF ANTIBIOTIC-RESISTANCE DURING THERAPY [J].
CHOW, JW ;
FINE, MJ ;
SHLAES, DM ;
QUINN, JP ;
HOOPER, DC ;
JOHNSON, MP ;
RAMPHAL, R ;
WAGENER, MM ;
MIYASHIRO, DK ;
YU, VL .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (08) :585-590
[8]   Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals - A challenge to hospital leadership [J].
Goldmann, DA ;
Weinstein, RA ;
Wenzel, RP ;
Tablan, OC ;
Duma, RJ ;
Gaynes, RP ;
Schlosser, J ;
Martone, WJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (03) :234-240
[9]   EFFECTS OF TAZOBACTAM ON THE FREQUENCY OF THE EMERGENCE OF RESISTANT STRAINS FROM ENTEROBACTER-CLOACAE, CITROBACTER-FREUNDII, AND PROTEUS-VULGARIS (BETA-LACTAMASE DEREPRESSED MUTANTS) [J].
HIGASHITANI, F ;
NISHIDA, K ;
HYODO, A ;
INOUE, M .
JOURNAL OF ANTIBIOTICS, 1995, 48 (09) :1027-1033
[10]   Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: Evaluation of a national postmarketing surveillance program [J].
Itokazu, GS ;
Quinn, JP ;
BellDixon, C ;
Kahan, FM ;
Weinstein, RA .
CLINICAL INFECTIOUS DISEASES, 1996, 23 (04) :779-784